A similar phenotype was identified in a Ptf1a–/– mouse model, where the severity of pancreatic hypoplasia, pancreatic exocrine insufficiency, and glucose intolerance was shown to correlate with the Ptf1a mRNA levels, suggesting a dosage-dependent effect (1). Here, PTF1A is linked to exocrine pancreatic insufficiency.